TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Yesterday

NL

Article

EBCapitalMarkets published an article 3:11 PM

3 Reasons Why Marijuana Stock GW Pharmaceuticals Could Fall

GW Pharma has been one of biotech's big winners thanks to a slate of promising marijuana-based drugs, but investors are right to wonder if the stock's winning ways will continue.

NL

Article

EBCapitalMarkets published an article 1:17 PM

Is it Time to Buy Cigna Corporation Stock?

Cigna doesn't participate in Obamacare exchanges as much as UnitedHealth Group and WellPoint, but shares may still be attractive to investors.

NL

Article

EBCapitalMarkets published an article 11:21 AM

5 Things Humana Inc. Management Wants You to Know

Here are five quotes from Humana's second quarter conference call that offers investors important insight.into whether or not to own shares.

Wed Aug 20

NL

Article

EBCapitalMarkets published an article 2:35 PM

3 Reasons Why HCA Holdings Inc Stock Could Rise

Higher insurance enrollments due to the Affordable Care Act is just one of three reasons why business could improve at HCA's 165 hospitals and 115 freestanding surgery centers.

Tue Aug 19

NL

Article

EBCapitalMarkets published an article 2:17 PM

3 Reasons WellPoint Inc Stock May Rise

WellPoint membership has climbed by 1.6 million people this year, which has helped its shares jump more than 22% year to date. Here are three reasons shares may continue to climb.

Mon Aug 18

NL

Article

EBCapitalMarkets published an article 10:57 AM

3 Reasons Express Scripts Holding Company Stock Could Fall

Express Scripts faces challenges given it operates in a hyper-competitive industry.

Tue Aug 5

NL

Article

EBCapitalMarkets published an article 4:58 PM

Medical Equipment Wholesale: Investing Essentials

Increasing health-care utilization tied to reform and an aging America supports sales growth for medical equipment wholesalers.

NL

Article

EBCapitalMarkets published an article 1:42 PM

Home Health Care: Investing Essentials

Aging baby boomers are driving demand for home health care, but the industry faces pricing hurdles given its reliance on Medicare.

Fri Aug 1

NL

Article

EBCapitalMarkets published an article 12:31 PM

Medical Devices: Investing Essentials

The constantly evolving medical device industry may offer investors significant opportunity by way of industry innovation and an aging global population.

Thu Jul 31

NL

Article

EBCapitalMarkets published an article 11:01 AM

Healthcare Information Services: Investing Essentials

An overview of what investors need to know about the healthcare information services industry and the drivers impacting it.

Tue Jul 29

NL

Article

EBCapitalMarkets published an article 11:47 AM

Congress and Hospitals Team Up For Veterans' Medical Care

The creation of a Veteran's Choice Fund to pay for veteran care at non-VA facilities could significantly decrease veteran wait-times for appointments.

Fri Jul 25

NL

Article

EBCapitalMarkets published an article 10:47 AM

Humira Still Key to AbbVie

AbbVie posted solid second-quarter results thanks to its top-selling Humira, but challenges remain from competitors such as Johnson & Johnson ahead of Humira's patent expiration.

Thu Jul 24

NL

Article

EBCapitalMarkets published an article 5:20 PM

Why Insurers Are Paying Out Rebates

Thanks to Obamacare, insurers including UnitedHealth Group (UNH), Humana (HUM), and Aetna (AET) are paying consumers millions in rebates.

NL

Article

EBCapitalMarkets published an article 4:01 PM

What Gilead Stock's Latest Blockbuster Approval Means for Investors

Gilead Science's (GILD) Zydelig won approval for use in chronic lymphocytic leukemia, follicular lymphoma, and small lymphocytic lymphoma.

NL

Article

EBCapitalMarkets published an article 2:53 PM

Celgene Stock Earnings: Key Takeaways

Celgene reported solid revenue and earnings for the second quarter, which may suggest investors are wrong to sell shares.

NL

Article

EBCapitalMarkets published an article 12:47 PM

3 Crucial Quotes From Gilead Sciences Stock

Here are three quotes from Gilead Sciences (GILD) management that offer clues as to whether the companies hepatitis C and HIV drug sales will grow through year end.

Wed Jul 23

NL

Article

EBCapitalMarkets published an article 5:53 PM

Is Gilead About to Crush Pharmacyclics Stock?

Gilead (GILD) won approval for Zydelig this week as a treatment for chronic lymphocytic leukemia, but that doesn't mean that Johnson & Johnson (JNJ) and Pharmacyclics' Imbruvica is heading for the dustbin.

NL

Article

EBCapitalMarkets published an article 2:02 PM

3 Can't-Miss Quotes From UnitedHealth Group's CEO

UnitedHealth Group's (UNH) second quarter earnings conference call offers three gems that could have implications for other insurers like WellPoint (WLP).

NL

Article

EBCapitalMarkets published an article 2:00 PM

5 Novartis Drugs You Need To Know About

Biogen (BIIB) and Regeneron (REGN) pose threats to Novartis' (NVS) sales as Diovan competitors launch.

NL

Article

EBCapitalMarkets published an article 1:33 PM

Decoding 4 Stocks' Big Earnings Moves

ConMed (CNMD) shares are dropping while Quidel (QDEL), Neogen (NEOG), and Vascular Solutions (VASC) shares are gaining double digits following earnings.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 61111 out of 75000
Score -287.01
Score Change Today -13.35
Accuracy 35.29%
Active Picks 34
Total Picks 34
Best Pick GILD (+57.02)
Worst Pick WFM (-49.63)
Average Score per Pick -8.44
Charms Earned 5
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts